Insider · CIK 0001709113

Cavanaugh Sarah

Reports to the SEC for 1 company · HAMPTON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001709113

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+95K sh	—	—	95,000
2025-06-05	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+78K sh	—	—	78,000
2024-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+78K sh	—	—	78,000
2024-05-30	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−20.9K sh	$33.73	−$703K	1,860
2024-05-30	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+10.8K sh	$2.78	+$29.9K	12,610
2024-05-30	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−10.1K sh	—	—	0
2024-05-30	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+10.1K sh	$9.02	+$91.1K	22,713
2024-05-30	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−10.8K sh	—	—	0
2023-06-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+75K sh	—	—	75,000
2022-08-18	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−1,355 sh	$36.38	−$49.3K	1,284
2022-08-18	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+1,355 sh	$9.02	+$12.2K	2,639
2022-08-18	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−1,355 sh	—	—	10,103
2022-08-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock OptionM Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−31.3K sh	—	—	10,750
2022-08-17	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+31.3K sh	$2.78	+$87K	32,596
2022-08-17	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−31.3K sh	$36.73	−$1.15M	1,284
2022-06-16	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+73K sh	—	—	73,000
2021-12-08	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−5,466 sh	—	—	78,534
2021-12-08	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−1,857 sh	—	—	11,458
2021-12-08	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−7,323 sh	$40.00	−$293K	408
2021-12-08	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+5,466 sh	$10.38	+$56.7K	7,731
2021-12-08	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+1,857 sh	$9.02	+$16.7K	2,265
2021-11-01	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−901 sh	$43.06	−$38.8K	2,528
2021-11-01	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+5,018 sh	$9.02	+$45.2K	6,793
2021-11-01	CLDXCelldex Therapeutics, Inc.M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	+938 sh	$2.78	+$2,607.64	7,731
2021-11-01	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−4,302 sh	$44.11	−$190K	3,429
2021-11-01	CLDXCelldex Therapeutics, Inc.S Sale	SVP OF CORP AFFAIRS & ADMIN.	SSale	−2,120 sh	$41.62	−$88.2K	408
2021-11-01	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−5,018 sh	—	—	13,315
2021-11-01	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (Right to Buy)M Exercise/Conversion	SVP OF CORP AFFAIRS & ADMIN.	MExercise/Conversion	−938 sh	—	—	42,062
2021-06-17	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+56K sh	—	—	56,000
2020-06-18	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+84K sh	—	—	84,000
2020-06-10	CLDXCelldex Therapeutics, Inc.P Purchase	SVP OF CORP AFFAIRS & ADMIN.	PPurchase	+1,050 sh	$4.83	+$5,071.5	1,367
2019-06-19	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+43K sh	—	—	43,000
2018-06-13	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+275K sh	—	—	275,000
2017-06-15	CLDXCelldex Therapeutics, Inc. · Incentive Stock Option (right to buy)A Award	SVP OF CORP AFFAIRS & ADMIN.	AAward	+65K sh	—	—	65,000

Recent filings

Accepted (ET)
Jun 294
Cavanaugh Sarah0001709113-26-000002
SEC(opens sec.gov)
Jun 94
Cavanaugh Sarah0001415889-25-016260
SEC(opens sec.gov)
Jun 174
Cavanaugh Sarah0001415889-24-017182
SEC(opens sec.gov)
Jun 34
Cavanaugh Sarah0001415889-24-015138
SEC(opens sec.gov)
Jun 204
Cavanaugh Sarah0001415889-23-010042
SEC(opens sec.gov)
Aug 194
Cavanaugh Sarah0001415889-22-008896
SEC(opens sec.gov)
Jun 174
Cavanaugh Sarah0001415889-22-006731
SEC(opens sec.gov)
Dec 104
Cavanaugh Sarah0001179110-21-010820
SEC(opens sec.gov)

Companies

Celldex Therapeutics, Inc.SVP OF CORP AFFAIRS & ADMIN.CLDX

Address

C/O CELLDEX THERAPEUTICS, INC. 53 FRONTAGE ROAD, SUITE 220

HAMPTON, NJ, 08827